I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
van Ommen – Nijhof, Annemiek
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (8)
OpenAccess-fulltext (3)
Sorted by: Relevance
Sorted by: Year
?
1
Erratum to "Prognostic factors in patients with oligometast..:
van Ommen – Nijhof, Annemiek
;
Steenbruggen, Tessa G.
;
Schats, Winnie
...
Cancer Treatment Reviews. 92 (2021) - p. 102138 , 2021
Link:
https://doi.org/10.1016/..
?
2
Prognostic factors in patients with oligometastatic breast ..:
van Ommen – Nijhof, Annemiek
;
Steenbruggen, Tessa G
;
Schats, Winnie
...
Cancer Treatment Reviews. 91 (2020) - p. 102114 , 2020
Link:
https://doi.org/10.1016/..
?
3
Survival and prognostic factors in oligometastatic breast c..:
van Ommen-Nijhof, Annemiek
;
Steenbruggen, Tessa G.
;
Capel, Laura
...
The Breast. 67 (2023) - p. 14-20 , 2023
Link:
https://doi.org/10.1016/..
?
4
Adjuvant aromatase inhibitor therapy and early markers for ..:
van Ommen-Nijhof, Annemiek
;
Jacobse, Judy N.
;
Steggink, Lars C.
...
Breast Cancer Research and Treatment. 196 (2022) 3 - p. 591-602 , 2022
Link:
https://doi.org/10.1007/..
?
5
Survival and prognostic factors in oligometastatic breast c..:
van Ommen-Nijhof, Annemiek
;
Steenbruggen, Tessa G
;
Capel, Laura
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795523/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
6
Adjuvant aromatase inhibitor therapy and early markers for ..:
van Ommen-Nijhof, Annemiek
;
Jacobse, Judy N
;
Steggink, Lars C
...
https://research.rug.nl/en/publications/fe84867a-0297-48ea-8b8f-372b0181c3f9. , 2022
Link:
https://hdl.handle.net/1..
?
7
Survival and prognostic factors in oligometastatic breast c..:
Annemiek van Ommen-Nijhof
;
Tessa G. Steenbruggen
;
Laura Capel
...
http://www.sciencedirect.com/science/article/pii/S0960977622002065. , 2023
Link:
https://doi.org/10.1016/..
?
8
Selecting the optimal position of CDK4/6 inhibitors in horm..:
On behalf of the SONIA study steering committee
;
van Ommen-Nijhof, A.
;
Konings, I. R.
...
BMC Cancer. 18 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1186/..
?
9
Efficacy and safety of daratumumab combined with all-transr..:
Frerichs, Kristine A.
;
Minnema, Monique C.
;
Levin, Mark-David
...
Blood Advances. 5 (2021) 23 - p. 5128-5139 , 2021
Link:
https://doi.org/10.1182/..
?
10
Lenalidomide combined with low-dose cyclophosphamide and pr..:
Franssen, Laurens E.
;
Nijhof, Inger S.
;
Bjorklund, Chad C.
...
Oncotarget. 9 (2018) 74 - p. 34009-34021 , 2018
Link:
https://doi.org/10.18632..
?
11
The Impact of the Transformation Toward Small-Scale Residen..:
van Schie, Lynn
;
Nijhof, Karin
;
Mulder, Eva
..
Residential Treatment For Children & Youth. 40 (2023) 4 - p. 445-463 , 2023
Link:
https://doi.org/10.1080/..
1-11
